BofA Securities Adjusts Avalo Therapeutics Price target to $24 From $29

MarketScreener · MT Newswires · 2026-11-06 13:15 UTC

Avalo Therapeutics Inc has an average rating of buy and mean price target of $36, according to analysts polled by FactSet. ...

Published on 11/06/2026 at 08:15 am EST

US Edition

- Homepage